Management of cancer-associated venous thrombosis

References

• AlcalayAWunTKhatriVVenous thromboembolism in patients with colorectal cancer: incidence and effect on survivalJ Clin Oncol20062411121816505431
   PubMed Web of Science ®Google Scholar
• AltinbasMCoskunHSErOA randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancerJ Thromb Haemost2004212667115304029
   PubMed Web of Science ®Google Scholar
• BalestreriLDe CiccoMMatovicMCentral venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic studyEur J Radiol199520108117588863
   PubMed Web of Science ®Google Scholar
• BergqvistDBurmarkUFlordalPLow molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis:2500 versus 5000 XaI units in 2070 patientsBr J Surg1995824965017613894
   PubMed Web of Science ®Google Scholar
• BergqvistDAgnelliGCohenADuration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancerN Engl J Med20023469758011919306
   PubMed Web of Science ®Google Scholar
• BernMLokichJWallachSVery low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trialAnn Intern Med199011242382178534
   PubMed Web of Science ®Google Scholar
• BonaRThrombotic complications of central venous catheters in cancer patientsSemin Thromb Hemost1999251475510357082
   PubMed Web of Science ®Google Scholar
• BullerHRAgnelliGHullRDAntitrombotic therapy for venous thromboembolic diseaseChest2004126421S428S
   Web of Science ®Google Scholar
• ChewHWunTHarveyDThe incidence of venous thromboembolism and its effect on survival among patients with common cancersArch Intern Med20061664586416505267
   PubMed Web of Science ®Google Scholar
• ClagettGPReischJSPrevention of venous thromboembolism in general surgical patientsAnn Surg1988208227402456748
   PubMed Web of Science ®Google Scholar
• DolovichLRGinsbergJSDouketisJDA meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism:examining some unanswered questions regarding location of treatment, product type, and dosing frequencyArch Intern Med2000160181810647756
   PubMed Web of Science ®Google Scholar
• GalsterHKolbGKohsytorzAThe pre-, peri-, and postsurgical activation of coagulation and the thromboembolic risk for different risk groupsThromb Res2000100381811150579
   PubMed Web of Science ®Google Scholar
• GeertsWHPineoGFHeitJAPrevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyChest2004126338S400S15383478
   PubMed Web of Science ®Google Scholar
• GouldMKDembitzerADDoyleRLLow-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trialsAnn Intern Med1999130800910366369
   PubMed Web of Science ®Google Scholar
• HeitJASilversteinMDMohrDNPredictors of survival after deep vein thrombosis and pulmonary embolism: A population based, cohort studyArch Intern Med19991594455310074952
   PubMed Web of Science ®Google Scholar
• HettiarachchiRJLokJPrinsMHUndiagnosed malignancy in patients with deep vein thrombosis: incidence, risk factors, and diagnosisCancer19988318059655309
   PubMed Web of Science ®Google Scholar
• HullRDPineoGFMahAFfor the LITE InvestigatorsA randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodiumJ Thromb Haemost20031Suppl 1OC395
   Google Scholar
• KakkarAKLevineMNKadziolaZLow molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)J Clin Oncol2004221944815143088
   PubMed Web of Science ®Google Scholar
• KarthausMKretzschmarAKroningHDalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trialAnn Oncol2006172899616317012
   PubMed Web of Science ®Google Scholar
• KhoranaAAMalignancy, thrombosis and Trousseau: the case for an eponymJ Throm Haemost2003124635
   PubMed Web of Science ®Google Scholar
• KlerkCPWSmorenburgSMOttenJMMBThe effect of low molecular weight heparin on survival in patients with advanced malignancyJ Clin Oncol2005232130515699479
   PubMed Web of Science ®Google Scholar
• LeeAYYLevineMNCancer and thrombosis: Current concepts in patient care2002ConnecticutChase Medical Communications
   Google Scholar
• LeeAYLevineMNBakerRILow molecular weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancerN Engl J Med20033491465312853587
   PubMed Web of Science ®Google Scholar
• LeeARicklesFRJulianJARandomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolismJ Clin Oncol2005232123915699480
   PubMed Web of Science ®Google Scholar
• LevineMHirshJGentMDouble-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerLancet199434388697908358
   PubMed Web of Science ®Google Scholar
• LevitanNDowlatiARemickSCRates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims dataMed (Baltimore)19997828591
   PubMed Web of Science ®Google Scholar
• LipGYChinBSBlannADCancer and the prothrombotic stateLancet Oncol20023273411908507
   PubMed Web of Science ®Google Scholar
• MeyerGMarjanovicZValckeJComparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled studyArch Intern Med200216217293512153376
   PubMed Web of Science ®Google Scholar
• MichaelsLCancer incidence and mortality in patients having anticoagulant therapyLancet196422832514197157
   PubMedGoogle Scholar
• MismettiPLaporteSDarmonJYMeta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgeryBr J Surg2001889133011442521
   PubMed Web of Science ®Google Scholar
• MonrealMAlastrueARullMUpper extremity deep venous thrombosis in cancer patients with venous access devices – prophylaxis with a low molecular weight heparin (Fragmin)Thromb Haemost19967525138815570
   PubMed Web of Science ®Google Scholar
• MonrealMLensingAWAPrinsMHScreening for occult cancer in patients with acute deep vein thrombosis and pulmonary embolismJ Throm Haemost2004287681
   PubMed Web of Science ®Google Scholar
• PrandoniPLensingAPiccioliARecurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood20021003484812393647
   PubMed Web of Science ®Google Scholar
• RasmussenMSWille-JorgensenPJorgensenLNProlonged thromboprophylaxis with low molecular weight heparin (dalteparin) following major abdominal surgery for malignancy [abstract]Blood2003102186
   Web of Science ®Google Scholar
• SaphnerTTormeyDCGrayRVenous and arterial thrombosis in patients who receive adjuvant therapy for breast cancerJ Clin Oncol19919286941988575
   PubMed Web of Science ®Google Scholar
• SorensenHTMellemkjaerLOlsenJHPrognosis of cancers associated with venous thromboembolismN Engl J Med200034318465011117976
   PubMed Web of Science ®Google Scholar
• van den BeltAGPrinsMHLensingAWFixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolismCochrane Database Syst Rev2000 CD001100
   PubMedGoogle Scholar
• WolffRAre patients with cancer receiving adequate thromboprophylaxis? Results from FRONTLINECancer Treat Rev200329Suppl 27912887943
   PubMedGoogle Scholar
• ZacharskiLRHendersonWGRicklesFREffect of warfarin on survival in small cell carcinoma of the lungJAMA198124583156257941
   PubMed Web of Science ®Google Scholar
• ZacharskiLRMalignancy as a solid-phase coagulopathy: implications for the etiology, pathogenesis, and treatment of cancerSemin Thromb Hemost2003292394612888928
   PubMed Web of Science ®Google Scholar